Johnson & Johnson delay European rollout of Covid vaccine amid blood clot fears
Johnson and Johnson is delaying the rollout of its single dose Covid vaccine in Europe over blood clot fears. American regulators have already suspended the rollout where six cases have been identified among 7 million doses. The move comes